Scholarlink

Background <p>Chronic atrophic gastritis (CAG) severity risk assessment remains challenging due to limitations of current static histologic/endoscopic tools. We evaluated the leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5)/trefoil factor 2 (TFF2) ratio — quantifying gastric stem cell niche imbalance— as a dynamic biomarker for high-risk CAG (OLGA/OLGIM III-IV).</p> Methods <p>In a retrospective cohort (<i>n</i> = 60 CAG patients), we constructed four prediction models (Baseline: demographics; Clinical: +<i>H. pylori</i>/family history; Endoscopic; Full: +LGR5/TFF2 ratio) using Firth penalized regression. Model performance was assessed via area under the curve (AUC), Akaike (AIC), and Bayesian (BIC) information criteria, and likelihood ratio tests. Restricted cubic splines and subgroup analyses validated threshold effects.</p> Results <p>The LGR5/TFF2 ratio &gt; 1.066 (AUC = 0.93) identified high-risk CAG with 48.5-fold increased odds (95% CI: 4.07–578.51, <i>P</i> = 0.002), outperforming endoscopic/histologic models (ΔAUC = + 0.15). A nonlinear dose-response relationship revealed sharp risk escalation beyond this threshold. The high-ratio group (<i>n</i> = 20) exhibited 60.00% prevalence of prior <i>H. pylori</i> eradication, Wnt activation (β-catenin↑32.3%, CyclinD1↑90%, <i>P</i> &lt; 0.001), and stronger endoscopic correlation (ρ = 0.42 for IM nodules) than traditional factors (ρ = 0.28 for <i>H. pylori</i>).</p> Conclusion <p>The LGR5/TFF2 ratio is the first biomarker to molecularly define CAG severity risk by quantifying stem cell niche imbalance (LGR5↑/TFF2↓), achieving superior accuracy (AUC = 0.93) and identifying high-risk cases missed by current methods. Its integration into clinical practice could transform risk-stratified surveillance paradigms.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The LGR5/TFF2 ratio as a stem cell biomarker predicts high-risk status in chronic atrophic gastritis: a retrospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月9日

查看全文
  • Qingqing Zhang,
  • Di Wu,
  • Fengyun Guo,
  • Shengnan Yang,
  • Lijing Bao,
  • Ruiying Zhang,
  • Ping Wang

摘要

Background

Chronic atrophic gastritis (CAG) severity risk assessment remains challenging due to limitations of current static histologic/endoscopic tools. We evaluated the leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5)/trefoil factor 2 (TFF2) ratio — quantifying gastric stem cell niche imbalance— as a dynamic biomarker for high-risk CAG (OLGA/OLGIM III-IV).

Methods

In a retrospective cohort (n = 60 CAG patients), we constructed four prediction models (Baseline: demographics; Clinical: +H. pylori/family history; Endoscopic; Full: +LGR5/TFF2 ratio) using Firth penalized regression. Model performance was assessed via area under the curve (AUC), Akaike (AIC), and Bayesian (BIC) information criteria, and likelihood ratio tests. Restricted cubic splines and subgroup analyses validated threshold effects.

Results

The LGR5/TFF2 ratio > 1.066 (AUC = 0.93) identified high-risk CAG with 48.5-fold increased odds (95% CI: 4.07–578.51, P = 0.002), outperforming endoscopic/histologic models (ΔAUC = + 0.15). A nonlinear dose-response relationship revealed sharp risk escalation beyond this threshold. The high-ratio group (n = 20) exhibited 60.00% prevalence of prior H. pylori eradication, Wnt activation (β-catenin↑32.3%, CyclinD1↑90%, P < 0.001), and stronger endoscopic correlation (ρ = 0.42 for IM nodules) than traditional factors (ρ = 0.28 for H. pylori).

Conclusion

The LGR5/TFF2 ratio is the first biomarker to molecularly define CAG severity risk by quantifying stem cell niche imbalance (LGR5↑/TFF2↓), achieving superior accuracy (AUC = 0.93) and identifying high-risk cases missed by current methods. Its integration into clinical practice could transform risk-stratified surveillance paradigms.